Brief: GC Biopharma gets CMO rights for shingles vaccine from Curevo Vaccine
13/10/2025 12:33
Oct 13 (Reuters) - GC Biopharma Corp 006280.KS: GC BIOPHARMA CORP - SECURES CMO RIGHTS FOR SHINGLES VACCINE FROM CUREVO VACCINE GC BIOPHARMA CORP - UNDER TERMS, CO TO PRODUCE PORTION OF COMMERCIAL SUPPLY OF AMEZOSVATEIN FOR GLOBAL MARKETS Source text: ID:nPn70RsVSa Further company coverage: 006280.KS (Reporting by Anhata Rooprai) ((Anhata.Rooprai@thomsonreuters.com;))
Recent news on GC Biopharma
See all newsBrief: Gc Biopharma Q2 Operating. Profit 1.7 Billion Won, Down 93.8% Y/Y
Brief: Gc Biopharma Corp 006280.Ks - Q1 Operating. Profit 11.7 Billion Won, Up 46% Y/Y
Brief: Green Cross Corp Q3 Operating Profit 29.2 Billion Won, Down 26.3% From Year Earlier
Brief: GC Biopharma gets CMO rights for shingles vaccine from Curevo Vaccine
Brief: Gc Biopharma Receives Marketing Authorization For Barycela In Vietnam